Skip to main content

Table 1 Measurement of tumor hypoxia in twelve feline head and neck tumors

From: Evaluation of hypoxia in a feline model of head and neck cancer using 64Cu-ATSM positron emission tomography/computed tomography

Cat:

Diagnosis

Location

Maximum dimension (cm)

Tmax/M

Tav/M

% PIM

pO2 1 (mmHg)

pO2 2 (mmHg)

pO2 3 (mmHg)

1

Polyp

Mandible

1.93

6.0

1.9

NE

32

5.5

0.6

2

Bone cyst

Maxilla

1.46

1.4

1.0

NE

61

68

NE

3

Eosinophilic granuloma

Sublingual

1.37

6.4

3.0

NE

NE

NE

NE

4

SCC

Maxilla

4.16

14

4.7

NE

1.7

4.73

NE

5

SCC

Mandible

4.32

11

4.8

50%

NE

NE

NE

6

SCC

sublingual

3.37

4.8

2.2

60%

1.8

40

0.8

7

SCC

Maxilla

4.66

22

5.2

NE

50

0.3

3.3

8

SCC

Mandible

4.41

11

3

NE

2.2

26.3

2.6

9

SCC

Maxilla

4.18

4.3

1.8

NE

0.3

0

0.5

10

FSA

Maxilla

4.42

7.3

3.3

NE

0.4

0.8

0.38

11

OSA

Maxilla

8.73

7.5

1.5

NE

6.5

10.7

2.1

12

OSA

Maxilla

5.11

6.2

2.2

Fig 1

NE

NE

NE

  1. Cats were assigned an arbitrary number from 1–12. The underlying etiology of the mass, location of the mass, maximum dimension of the mass, as well as values for the three diagnostic tests are provided. Tmax/M is a ratio of maximum 64Cu-ATSM uptake over muscular uptake as a normalization for signal to background uptake, Tav/M is the average uptake over the entire mass, %PIM is the percentage of pimonidazole uptake, and pO2 is the measured oxygen pressure with a fluorescent life-time probe. HNSCC = squamous cell carcinoma, FSA = fibrosarcoma, OSA = osteosarcoma, NE = not evaluated, due to technical error.